Persist AI, the AI-driven pioneer in drug formulation, announced today the close of an oversubscribed $4M financing round following their completion of YCombinator, the prestigious San Francisco based startup accelerator. The funding round was led by 2048 Ventures with the participation of Innospark Ventures, Fellows Fund, YCombinator, Pioneer Fund, and others.
Company Information
Company
Persist AI
Location
890 Embarcadero Dr.
West Sacramento, California, United States
About
Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023.
Fundz sees it the moment Persist AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
West SacramentoManufacturingBiotechnologyHealth CareArtificial IntelligencePharmaceutical